Fauci says public health has ‘hit a wall’ and now is the time when ‘mandates come in’
Dr. Anthony Fauci of the National Institute of Allergies and Infectious Diseases says now is the time for COVID vaccine mandates. He appeared on the Daily Show with Trevor Noah Monday to call for more mandates. Monday was the first live recording for the show since the pandemic began. Yet, Fauci phoned in for the interview.
“This is a public health issue, and, as you said very appropriately a moment ago, the common enemy is the virus,” Fauic told host Trevor Noah. “There shouldn’t be the divisiveness that we’re seeing.”
As a result of the “divisiveness,” Fauci says the solution is mandating that everyone get vaccinated. “We’re trying to convince people but you’re reaching a certain point that you almost hit a wall that you’re not going to get to a certain group of people. That’s where mandates come in,” Fauci said. “No one likes to mandate people to do things they may not want to do, but sometimes for the greater good of society, you have to do that. You know, same thing like seat belts and things like that. You have to do it.”
Meanwhile, the Center of Disease Control and Prevention reported Monday that over 209 million Americans have received at least one does of the vaccine. Now 53,9% of them are fully vaccinated.
You can follow Jenny Goldsberry on Twitter @jennyjournalism.
You may like
FDA will work with China to import cancer drugs due to U.S. shortages
Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.
Foreign Desk News writes:
Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.
“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.
Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.
“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.
The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4
— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023
Foreign Desk News adds:
The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.
You may like
Economy5 days ago
New York City Mayor Eric Adams Proposes Housing Asylum Seekers in Private Homes
Economy5 days ago
Texas Gov Abbott aims to eliminate property taxes: ‘we must dream big’
Immigration4 days ago
Biden Administration to allow 40,000 asylum-seekers per month into US with mobile app
International4 days ago
Saudi Arabia-Israel Deal Remains Biden’s Win to Lose